 |
|
| |
 |
As an independent research firm, Rubicon offers its
services for sale to both institutional and retail
investors. We provide our research for purchase on
an individual report basis, or as a monthly, quarterly,
or annual subscription. Multiple subscription services
enable investors to target their area of interest.
|
|
| Service Level |
Monthly
Fee |
Quarterly
Fee |
Annual
Fee |
| |
|
|
|
| Full Access |
$5,000 |
$12,500 |
$45,000 |
| Investment Access Only |
$1,800 |
$5,000 |
$18,000 |
| Special Events Access Only - Full |
$3,500 |
$10,000 |
$35,000 |
| Special Events Access Only - Calendar Only |
$600 |
$1,800 |
$5,000 |
|
Full Access
Full access subscribers have unlimited access to all the
reports, as well as telephone access to our analysts to
discuss the reports, email alerts, and hosted conference
calls.
Investment Access Only
Investment access subscribers have access to the investment
recommendation reports as well as the analysts. The investment
reports provide comprehensive coverage on selected companies,
including our analysis of the business, products, and markets;
an analyses of competition; a financial model; and an investment
recommendation and target price.
Special Events Access Only
This service provides subscribers with access to only the
healthcare special events. These reports offer details of
specific drug events. Each report discusses the drug, the
upcoming event, our expectation on the event's outcome,
and the market opportunity for the drug, including competition.
These reports DO NOT provide an investment recommendation
for the stock; they simply provide an analysis of the event
and its expected timing.
| Report Type |
Price |
| |
|
Investment Report
|
$495.00 |
Special Events Reports
|
$300.00 |
Previous Event Report
|
$100.00 |
Special Events Calendar
|
$300.00 |
Special Events Calendar – Next 10 Events
|
$300.00 |
Special Events Calendar – Next 30 Events
|
$400.00 |
| Special Events Performance Summary report |
$1000.00 |
Special Events Calendar
The Special Events calendar displays the company, the specific
healthcare event, drug indication and expectation, as well
as the peak sales potential relative to the market cap for
the drug (not available in the limited view versions).
Special Events Performance Summary
The Special Events performance summary report displays past
events, the outcome relative to the expectations, and the
stock performance.
|
|
